Summit Financial Group, Inc. Johnson & Johnson Transaction History

Summit Financial Group, Inc.

$279 Million
Q1 2024

A detailed history of Summit Financial Group, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Summit Financial Group, Inc. holds 36,635 shares of JNJ stock, worth $5.88 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares

36,635

Previous 36,821 0.51%

Holding current value

$5.88 Million

Previous $5.77 Million 0.42%

% of portfolio

2.08%

Previous 2.22%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$155.22 - $162.74 $28,870 - $30,269	-186 Reduced 0.51%	36,635 $5.8 Million
Q4 2023 Jan 12, 2024	SELL	$145.6 - $158.88 $64,355 - $70,224	-442 Reduced 1.19%	36,821 $5.77 Million
Q3 2023 Oct 17, 2023	SELL	$155.75 - $174.48 $127,403 - $142,724	-818 Reduced 2.15%	37,263 $5.8 Million
Q2 2023 Jul 13, 2023	SELL	$154.35 - $166.11 $131,197 - $141,193	-850 Reduced 2.18%	38,081 $6.3 Million
Q1 2023 Apr 11, 2023	SELL	$151.05 - $180.26 $38,517 - $45,966	-255 Reduced 0.65%	38,931 $6.03 Million
Q4 2022 Jan 09, 2023	SELL	$160.2 - $179.79 $3,524 - $3,955	-22 Reduced 0.06%	39,186 $6.92 Million
Q3 2022 Oct 12, 2022	SELL	$161.33 - $179.52 $1,451 - $1,615	-9 Reduced 0.02%	39,208 $6.41 Million
Q2 2022 Jul 07, 2022	SELL	$168.19 - $186.01 $125,301 - $138,577	-745 Reduced 1.86%	39,217 $6.96 Million
Q1 2022 Apr 08, 2022	BUY	$158.14 - $179.59 $44,595 - $50,644	282 Added 0.71%	39,962 $7.08 Million
Q4 2021 Jan 10, 2022	BUY	$155.93 - $173.01 $49,429 - $54,844	317 Added 0.81%	39,680 $6.79 Million
Q3 2021 Oct 08, 2021	SELL	$161.5 - $179.47 $5,652 - $6,281	-35 Reduced 0.09%	39,363 $6.36 Million
Q2 2021 Jul 06, 2021	BUY	$159.48 - $171.07 $196,957 - $211,271	1,235 Added 3.24%	39,398 $6.49 Million
Q1 2021 Apr 07, 2021	SELL	$153.07 - $170.48 $133,630 - $148,829	-873 Reduced 2.24%	38,163 $6.27 Million
Q4 2020 Jan 07, 2021	SELL	$137.11 - $157.38 $64,030 - $73,496	-467 Reduced 1.18%	39,036 $6.14 Million
Q3 2020 Oct 05, 2020	SELL	$140.38 - $153.83 $44,360 - $48,610	-316 Reduced 0.79%	39,503 $5.88 Million
Q2 2020 Jul 06, 2020	BUY	$128.81 - $155.51 $20,609 - $24,881	160 Added 0.4%	39,819 $5.6 Million
Q1 2020 Apr 03, 2020	SELL	$111.14 - $153.99 $5,668 - $7,853	-51 Reduced 0.13%	39,659 $5.2 Million
Q4 2019 Jan 06, 2020	SELL	$127.5 - $146.44 $15,937 - $18,305	-125 Reduced 0.31%	39,710 $5.79 Million
Q3 2019 Oct 09, 2019	SELL	$126.95 - $142.14 $1.52 Million - $1.7 Million	-11,981 Reduced 23.12%	39,835 $5.15 Million
Q2 2019 Jul 03, 2019	SELL	$131.15 - $144.24 $455,615 - $501,089	-3,474 Reduced 6.28%	51,816 $7.22 Million
Q4 2018 Jan 04, 2019	SELL	$122.84 - $147.84 $10,441 - $12,566	-85 Reduced 0.15%	55,290 $7.14 Million
Q2 2018 Jul 03, 2018	SELL	$119.4 - $131.76 $4,776 - $5,270	-40 Reduced 0.07%	55,375 $6.72 Million
Q1 2018 Apr 04, 2018	BUY	$125.1 - $148.14 $167,634 - $198,507	1,340 Added 2.48%	55,415 $7.1 Million
Q4 2017 Jan 04, 2018	SELL	$131.22 - $143.62 $132,532 - $145,056	-1,010 Reduced 1.83%	54,075 $7.56 Million
Q3 2017 Oct 10, 2017	BUY	$129.47 - $135.38 $7.13 Million - $7.46 Million	55,085	55,085 $7.16 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $420B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.

Account

Summit Financial Group, Inc. Johnson & Johnson Transaction History